Wegovy is a prescription GLP-1 for chronic weight management. Learn how it works, dosing, cost, side effects, and how to get a prescription safely.
Wegovy is an FDA-approved prescription medication for chronic weight management, and its active ingredient is semaglutide, a GLP-1 receptor agonist. In the STEP clinical trials, adults using Wegovy alongside diet and exercise lost an average of roughly 15% of their starting body weight over about 68 weeks. It is a long-term treatment rather than a short course, and it requires a prescription and ongoing medical monitoring.
How Wegovy Works in the Body
Semaglutide mimics glucagon-like peptide-1, a hormone your gut releases after you eat. By acting on those same receptors, Wegovy changes several appetite and digestion signals at once.
- Appetite: it reduces hunger signaling in the brain, which can make smaller portions feel satisfying.
- Fullness: it slows how quickly the stomach empties, so you stay full longer.
- Blood sugar: it increases insulin release when glucose is high and reduces glucagon release when it is not.
Wegovy is made by Novo Nordisk and is usually given as a once-weekly injection under the skin. An oral semaglutide tablet for weight management has also been developed, and its dosing and pricing differ from the injectable form.
Who Qualifies for a Wegovy Prescription
Wegovy is approved for adults with a body mass index of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
It is also approved for some adolescents aged 12 and older with obesity, and for lowering cardiovascular risk in adults who have established heart disease plus excess weight. Eligibility rules vary, so a licensed clinician needs to review your history.
Wegovy is not right for everyone. It is not recommended for people with a personal or family history of medullary thyroid cancer or with multiple endocrine neoplasia syndrome type 2, and it is not for use during pregnancy.
Wegovy Dosing Schedule
Treatment starts at a low dose and increases every four weeks. The slow step-up is designed to let your body adjust and to limit nausea.
| Weeks | Weekly Wegovy dose | Purpose |
|---|---|---|
| 1-4 | 0.25 mg | Starter dose, not intended for weight loss yet |
| 5-8 | 0.5 mg | First increase |
| 9-12 | 1 mg | Step-up |
| 13-16 | 1.7 mg | Step-up |
| 17 and beyond | 2.4 mg | Maintenance dose for most adults |
If side effects are hard to tolerate, a prescriber may pause the increase or step the dose back down. Anyone using the tablet form should follow the current wegovy pill dosing chart, because oral dosing is not identical to the injection schedule.
Wegovy Price and Insurance Coverage
The wegovy price you pay depends heavily on your insurance, your pharmacy, and whether you use a manufacturer savings program.
List prices have been reported above $1,300 per month, while cash-pay programs from the manufacturer have been advertised in the several-hundred-dollar range. Coverage for novo nordisk wegovy varies by plan, and prior authorization is usually required.
- Commercial insurance often covers Wegovy when prior authorization and a documented BMI or diagnosis are provided.
- Manufacturer savings cards can lower out-of-pocket costs for people with commercial coverage.
- Medicare Part D coverage for obesity medications has historically been limited, though rules and pilot programs continue to change.
- Direct cash-pay pharmacy programs may be the least expensive path for people with no coverage.
How to Get a Wegovy Prescription
If you are wondering how to get wegovy pill prescription online, telehealth is the most common starting point. The process is straightforward, but it still requires a licensed prescriber.
- Complete an intake form with your height, weight, medical history, and current medications.
- Meet with a licensed clinician by video or phone to confirm eligibility.
- Have the prescription sent to a certified pharmacy, since many programs ship directly.
- Review the dose escalation plan and schedule follow-up check-ins.
Be cautious with any site that sells semaglutide without a prescription or without a clinician review. Legitimate telehealth providers verify identity and medical history before prescribing.
Side Effects and Safety
Most side effects are digestive and tend to appear during dose increases. Common ones include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and fatigue.
Less common but serious risks include pancreatitis, gallbladder disease, kidney problems from dehydration, and gastroparesis. People taking insulin or sulfonylureas may need dose adjustments because of low blood sugar risk.
Contact a healthcare professional promptly if you have severe or persistent abdominal pain, signs of dehydration, or symptoms that do not improve. Do not start, stop, or change a dose without medical guidance.
How Wegovy Compares With Other Options
| Option | Active ingredient | How it is taken | Approved for weight loss |
|---|---|---|---|
| Wegovy | Semaglutide | Weekly injection; oral tablet form also developed | Yes |
| Ozempic | Semaglutide | Weekly injection | No - approved for type 2 diabetes |
| Zepbound | Tirzepatide | Weekly injection | Yes |
| Compounded semaglutide | Semaglutide from unapproved sources | Injection | No |
Wegovy and Ozempic contain the same drug but are approved for different uses and come in different dose strengths. Zepbound targets two hormone pathways instead of one and has shown greater average weight loss in trials, but it is a separate prescription with its own side effect profile.
Beware of Unapproved Alternatives
Search interest in gray-market products often overlaps with GLP-1 searches. Questions such as what is bpc-157 made of appear alongside weight-loss queries, but BPC-157 is not FDA-approved for human use in the United States.
Compounded semaglutide was widely sold during the shortage, but the FDA has determined that the semaglutide shortage is resolved, which sharply limits legal compounding. Unverified injectables can contain the wrong dose, undisclosed ingredients, or contamination.
Key Takeaways
- Wegovy is an FDA-approved semaglutide injection for chronic weight management in eligible adults and adolescents.
- Average weight loss in clinical trials was about 15% of body weight over roughly 68 weeks.
- Doses increase every four weeks until a maintenance dose of 2.4 mg is reached, if tolerated.
- Cost and coverage vary widely, so check your plan and any manufacturer programs before starting.
- Wegovy is a prescription medicine and should be used under the supervision of a healthcare professional.
Frequently Asked Questions
How much weight can you lose on Wegovy?
In the STEP clinical trials, adults taking Wegovy plus diet and exercise lost about 15% of their body weight on average over roughly 68 weeks. Individual results vary widely, and some participants lost considerably more or less. Weight often returns if the medication is stopped without lasting changes to diet and activity.
Is Wegovy the same as Ozempic?
Wegovy and Ozempic both contain semaglutide, but they are approved for different purposes. Ozempic is approved for type 2 diabetes, while Wegovy is approved for chronic weight management and cardiovascular risk reduction in eligible patients. Wegovy is also available in higher dose strengths than Ozempic.
How much does Wegovy cost without insurance?
Historically, the list price of Wegovy has been reported above $1,300 per month without insurance. Manufacturer cash-pay pharmacy programs have been advertised in the several-hundred-dollar range, and pricing has changed multiple times. Check current pricing directly with the manufacturer or your pharmacy, since programs and eligibility rules change frequently.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.